Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
Valion Bio's CDMO subsidiary Velocity Bioworks completed an initial feasibility evaluation of partner LarmorBio's BioScan-NMR platform for biologics manufacturing monitoring. The test showed NMR signals strongly correlated with OD600 cell-density measurements, suggesting potential to track microbial fermentation growth in real time without invasive sampling.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.